Back
Innovator US Eq Acltd 9 Bfr ETFTM April Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
57
XBAP
Innovator US Eq Acltd 9 Bfr ETFTM April
Last Price:
33.45
Seasonality Move:
4.45%
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
313.03
Seasonality Move:
31.67%
Buy
57
Innovator US Eq Acltd 9 Bfr ETFTM April (XBAP)
is a Buy
Is Innovator US Eq Acltd 9 Bfr ETFTM April a Buy, Sell or Hold?
- The current Innovator US Eq Acltd 9 Bfr ETFTM April [XBAP] share price is $33.35. The Score for XBAP is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- XBAP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XBAP Stock Price Chart
What is Innovator US Eq Acltd 9 Bfr ETFTM April's stock price today?
-
The Innovator US Eq Acltd 9 Bfr ETFTM April share price today is $33.35
The current trend is moderately bearish and XBAP is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
XBAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 47.32 | Sell |
| Chaikin Money Flow: | -4874 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.31 - 33.57) | Sell |
| Bollinger Bands (100): | (32.23 - 33.31) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.45 | Buy |
| Relative Strength Index (14 RSI): | 74.74 | Buy |
| Chaikin Money Flow: | 898979 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.29 - 223.91) | Buy |
| Bollinger Bands (100): | (221.8 - 277.54) | Buy |
XBAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.53 | Sell |
| 20-day SMA: | 33.48 | Sell |
| 50-day SMA: | 33.19 | Buy |
| 200-day SMA: | 31.93 | Buy |
| 8-day EMA: | 33.5 | Sell |
| 20-day EMA: | 33.45 | Sell |
| 50-day EMA: | 33.19 | Buy |
| 200-day EMA: | 31.96 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 216.22 | Buy |
| 20-day SMA: | 214.16 | Buy |
| 50-day SMA: | 227.04 | Buy |
| 200-day SMA: | 240.71 | Buy |
| 8-day EMA: | 223.2 | Buy |
| 20-day EMA: | 218.42 | Buy |
| 50-day EMA: | 226.38 | Buy |
| 200-day EMA: | 233.63 | Buy |
Innovator US Eq Acltd 9 Bfr ETFTM April Earnings Growth & XBAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.
Innovator US Eq Acltd 9 Bfr ETFTM April Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||